ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000236519.1	Avagacestat	Bladder urothelial carcinoma	0.02563727	Resistant
ENSG00000236519.1	Avagacestat	Breast invasive carcinoma	0.002092758	Sensitive